|
Manager Clinical Quality Assurance Corcept is a commercial-stage company engaged in the discovery and development of drugs to treat severe endocrine, metabolic, oncologic and neurological disorders by modulating the effects of the hormone cortisol. Since 2012, we have marketed Korlym for the treatment of patients suffering from Cushing's syndrome, a life-threatening orphan disorder caused by excess cortisol activity. In 2022, we generated revenue of $402 million and net income of $101 million. We have discovered a portfolio of. After registering you may be able to apply for this job directly (if still active) on (Corcept Therapeutics)'s site. Future job matches may be sent from Geebo approved job partners.
|